Celularity Inc.

CELU | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.18

-$0.06 (-4.84%)

Sep 22, 2026, 12:57 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.84%

(1D)

Rating

Updated: Aug 28, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $34.16M

1D Range

1.16 1.26

52W Range

0.56 2.55

Valuation (TTM)

PE -0.45

PB -0.94

EV/EBITDA -1.26

Valuation (NTM)

Forward PE 0.93

Forward PEG 0.00

Price Target $3

Cash Flow

FCF Yield -36.9%

SBC Adj. FCF Yield -65.8%

SBC Impact -78.3%

Margins

Gross Margin 76.0%

Operating Margin -230.9%

FCF Margin -49.9%

Growth (CAGR)

Revenue 3Y | 5Y 13.9% | 13.2%

Dil EPS 3Y | 5Y 77.1% | 72.0%

FCF 3Y | 5Y 70.7% | 59.0%

Returns

ROA -85.5%

ROE 411.5%

ROIC -151.1%

Financial Health

Net Debt

$61.99M

Current Ratio 0.15

Interest Coverage -9.08

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments ...

Sector Healthcare

Industry Biotechnology

Employees 115

IPO Date Aug 7, 2019

Website www.celularity.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.